Influenza sector continues to strengthen, Beida Pharmaceutical hits limit up.

The influenza sector continues to strengthen, with Beida Pharmaceutical hitting the daily limit up, Hendi Pharmaceutical rising by over 10%, while Hualan Vaccine, Jinshiya Pharmaceutical, and Teyi Pharmaceutical are also following the trend. In terms of news, it is reported that in recent times, influenza activity in China has significantly increased, with the vast majority of provinces entering the influenza season.